Drug Type TCR therapy |
Synonyms Epstein Barr virus related nasopharyngeal carcinoma(Lion TCR), LT-C50, LTCR-N1-1 |
Target |
Mechanism EBV Protein inhibitors, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nasopharyngeal Carcinoma | Preclinical | SG | Lion TCR Pte Ltd.Startup | 23 Sep 2021 |